FDA Expands Sunscreen Options for the First Time in 20 Years
FDA adds bemotrizinol to permitted sunscreen active ingredients, expanding options for the first time in 20 years.
Aforeworn detected this change in the Pharmaceutical Manufacturing (FDA/DEA) space on July 27, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Low urgency. Branded drug makers, generic/ANDA manufacturers, API & contract manufacturers, compounding outsourcing (503B) should confirm how it applies to their specific situation before acting. There is a time constraint attached: None; effective immediately upon publication.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmaceutical Manufacturing (FDA/DEA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
FDA added bemotrizinol to the list of permitted sunscreen active ingredients (21 CFR 352.10).
Who it affects
Branded drug makers, generic/ANDA manufacturers, API & contract manufacturers, compounding outsourcing (503B)
What you must do
Review new ingredient for potential product development or reformulation; no immediate compliance action needed.
Deadline
None; effective immediately upon publication.
Source: http://www.fda.gov/news-events/press-announcements/fda-expands-sunscreen-options-first-time-20-years
Never miss a change like this again
Aforeworn watches Pharmaceutical Manufacturing (FDA/DEA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmaceutical Manufacturing (FDA/DEA)
- Continuing the Suspension of Duty-Free De Minimis Treatment for All Countries
- FDA Issues Draft Guidance to Cut Unnecessary Animal Testing for Cancer Drugs
- FDA Issues Draft Guidance to Help Accelerate Cell and Gene Therapies for Patients
- FDA Issues Emergency Use Authorization for Generic Over-the-Counter Drug to Treat New World Screwworm in Dogs and Cats
- FDA Broadens Access to Over-the-Counter Naloxone Nasal Spray for Opioid Overdose